Repeated administration of thioacetam ide (TA), either intraperitoneally or in drinking water, produced liver cirrhosis in normal Sprague-Dawley rats (SDR ) with signi®cant histological alterations similar to those observed in human cirrhosis. In the present study, we evaluated the ability of TA to induce liver cirrhosis in mutant Nagase analbum inaemic SDR.
Summary
Repeated administration of thioacetam ide (TA), either intraperitoneally or in drinking water, produced liver cirrhosis in normal Sprague-Dawley rats (SDR ) with signi®cant histological alterations similar to those observed in human cirrhosis. In the present study, we evaluated the ability of TA to induce liver cirrhosis in mutant Nagase analbum inaemic SDR.
T hioacetamide was administered either intraperitoneally up to 4 months or in drinking water up to 6 months to normal and to Nagase analbum inaemic SDR. Nagase analbum inaemic rat s (NAR ) were also administered TA in drinking water up to 10 months. Liver cirrhosis development was determined by macroscopic and microscopic analysis.
In contrast to normal SDR, no histological characteristics of cirrhosis could be observed in NAR submitted to a 4 or 6 months treatm ent with TA. Such failure to induce cirrhosis in Nagase rats was con®rmed even after prolonged TA administrati on in drinking water for up to 10 months. In contrast, ®brosis and cholangiolar proliferation occurred in the 10-m onth TAtreated analbum inaem ic rats, suggesting that the mechanisms involved in cirrhosis induction are different from those involved in ®brosis development and carcinogenesis. It is unlikely that the protective effect against TA-induced cirrhosis observed in analbum inaemic rats is related to the absence of albumin in this rat strain, since a co-administration of TA with album in in analbum inaem ic rats did not restore the potential for TA to induce cirrhosis in this rat strain.
In conclusion, the fact that induction of cirrhosis by TA is prevented in the inherently hyperlipidaem ic and hypercholesterolaemic analbum inaemic rats could be considered for potential applicati on in the treatm ent of clinical cirrhosis.
Keywords T hioacetamide; Nagase analbum inaem ic rats; cirrhosis; hyperlipidaemia; hypercholesterolaemia T hioacetamide (TA), originally used as fungicide, is a well known hepatotoxi c agent, potent in several animal species, which produces centrilobular necrosis (Moreira e t a l. 1995a), cirrhosis and hepatocarcinoma 1996 ) . We recently assessed the liver engraftm ent rat e of spleen-transplant ed hepatocytes of SDR origin, i.e. albumin-positive hepatocytes, into NAR recipients characterized by albumin-negative liver hepatocytes (David e t a l. 2001) . We have shown that only an average of 5±6 6 10 6 hepatocytes were engrafted per recipient liver and that the functionality of the transplanted hepatocytes was transitory. Recent studies have reported that engraftment and functionality of transplanted hepatocytes were drastic ally improved in recipients with liver failure through recipient hepatocyte destruction (Lac oni e t a l. 1998, 1999, Oren e t a l. 1999 ). T he aim of the present study was to evaluate the abil ity of TA to induce cirrhosis in the NAR rat strain, which would allow the assessment of both the engraftm ent rat e and the functionality of transplanted hepatocytes in a model of chronic liver fail ure. T he authors report that TA induced liver cirrhosis in SDR, as previously reported, but failed to induce liver cirrhosis in NAR and that this could be related to their inherent hyperlipidaemia and hypercholesterolaemia.
Methods

Anim a ls
Nagase analbum inaem ic rats at 3 months of age, weighing 250±300 g, were obtained from T GC Inc. (Sagam ihara-Shi, Japan ) and were propagated in our anim al care facility. Sprague-Dawley rats, weighing 250±300 g were purchased from Janvier (CERJ, France). All animals were maintain ed on dail y cycles of alternating 12 h light/darkness with food and water a d lib it um . All the experiments were conducted according to the local institutional guidelines for the care and the use of laboratory animals.
Tre a tm e nts
To induce macronodular cirrhosis (Zimmermann e t a l. 1986 ), anim als of the experimental groups received drinking water containing 0.45 g/l of TA for 6±10 months or intraperitoneal injection 3 times/week of a 4% TA saline solution (w/v) for 4 months.
For our experiments, the anim als were grouped as following: 
Histo pa th o lo gy
At the end of treat ment, the animals were killed (sodic pentobarbital [Sanofo, France] 6 mg=100 g body weight), the liver was immediatel y removed and samples were taken off. T he sam ples were ®xed in 5% form alin solution (v/v), dehydrated in acetone and embedded in paraf®n wax. Five micrometre sections were cut and stained with trichrome for light microscopic examinations of cirrhosis. In parallel, haematoxylin±eosin staining was performed.
Triglyce rid e s a nd to tal c h o le ste ro l a na lysis
Blood was collected from the rat tail vein under ether anaesthesia in heparinized tubes (Vacutainer 1 , Becton Dickinson, France) and centrifuged at 3000 g for 10 min. Triglycerides and total cholesterol analysis were performed by means of re¯ectometry using an automat ic Kodak Ektach em 500 analyzer.
Sta tistic a l a na lysis
Values are given as means SD. Statistical analysis was performed using the Stat view analysis software package (Abacus Concepts Inc., Berkeley, CA). Comparisons were made using Student's t-test. A difference was considered signi®cant when the P value was less than 0.05. Table 1 shows that NAR used in the present experiment had very low serum album in concentrat ions compared to SDR (0.025 0.005 vs 30 5 mg/ml). In contrast, Effect of thioacetamide in analbuminaemic ratscharacteristic of cirrhosis (A), while livers from NAR treated with TA were highly smooth at their surface (B).
Results
T his macroscopic observation was con®rmed microscopically by liver histological examinations (Fig 2) . Indeed, TA administrat ion to SDR, either in drinking water for 6 months (Group 1) or intraperitoneally for 4 months (Group 4), induced macronodular cirrhosis. Hepatic parenchyma totally consisted of 0.5±4 mm nodules (Fig 2A) , within which hepatocytes showed clari®cat ion, vacuolar transformation and swelling as well as anisocaryosis. Some mitoses and single cell necrosis were also observed. In contrast, we found that TA administrat ion to NAR for 6 months in drinking water (Group 2) or intraperitoneally for 4 months (Group 5) did not result in cirrhosis (Fig 2B) . Histological examinati ons of NAR livers receiving a co-injection of TA and albumin (Group 6) also did not result in the development of liver cirrhosis (data not shown). Even when TA treatm ent was prolonged up to 10 months (Group 3) no cirrhosis occurred (Fi g 3A) . Nevertheless, in Group 3, liver parenchyma contained numerous large areas of cholangiolar proliferat ion, embedded within ®brosis (Fi g 3B).
Between these areas that resembled cholangiomas, lobules and portal tracts were most often normal, with only occasionally ®ne ®brous septae (Fig 3C) . Moreover, in some lobules, hepatocellular trabec ulae were entirely replaced by ductular-li ke structures (Fig 3D ) .
Discussion
Repeated administration of TA either intraperitoneally up to 4 months or in drinking water up to 6 months produced liver cirrhosis in normal SDR with signi®cant histological alterations, similar to those observed in human cirrhosis as it has been already described by several authors (Hruban e t a l. 1966, Zimmermann e t a l. 1986). In contrast, no histological charac teristics of cirrhosis could be observed in NAR submitted to the same treatm ent protocol with TA. Such a failure to induce cirrhosis was con®rmed even after a prolonged TA administration in drinking water up to 10 months.
It is unlikely that the protective effect against TA toxicity observed in NAR is related to the absence of albumin in this rat strain, since we have found in the present study that a co-adm inistration of TA with albumin in NAR rats did not restore the cirrhogenic potential of TA in this strain of rats.
It is more likely that the hyperlipidaemia and hypercholesterolaem ia of this rat strain (see Table 1 ), resulting from extrahepati c lipogenesis and previously reported by several authors (Nagase & Shimamune 1979, Joles e t a l. 1993 ), could be directly related to the failure of TA to induce cirrhosis. Indeed, several studies have shown that PUFA or cholesterol dietary supplementation or enteral or parenteral lipids emulsion administration were able to prevent necrosis, in¯am mation and, ®nally, the cirrhotic process in TA-treated (Moreira e t a l. 1995a, Cervinkova e t a l. 1998, Esteban e t a l. 1999 ) or alcoholic (Nanji e t a l. 1997 ) rats.
Muller e t a l. (1991 ) described TA as a potent centrilobular hepatotoxic agent act ing by lipid peroxidation. T hey demonstrated that a reduction of the hepatic content of essential fatty acids (EFA), such as linoleic acid (18:2 ) and arac hidonic acid (20:4), was observed in TA-induced macronodular liver cirrhosis. T his was accompanied by a decrease in the hepatic content of PUFA, as also described by others (Moreira e t a l. 1995a,b, Buko e t a l. 1997 ). It is well known that hepatocellular injury and necrosis can be restored if a suf®cient energetic stat us is provided to the remaining periportal hepatocytes to allow them to regenerate. Chanda e t a l. (1994 ) have demonstrated that in TA-treated rats, the remaining periportal hepatocytes used fatty acid oxidation as a major cellular energetic source for liver regeneration. T hus, the fatty acid and cholesterol overload of NAR could either reduce EFA or PUFA depletion induced by lipid peroxidat ion following TA treatm ent and/or could be used as a cellular energetic source by residual periportal hepatocytes for hepatic regeneration, resulting in the protection of the liver from the cirrhogenic process of prolonged exposure to TA. Recent work by Mehendale's group has demonstrated that the outcome of TA bioactivation-m ediated liver injury is largely dependent on an adequate and timely tissue repair response (Wang e t a l. 2000b (Wang e t a l. , 2001 . Previous work of this group has shown that the source of cellular energy can decisively in¯uence the compensatory response of the target tissue to alt er the hepatotoxi c outcome of hepatotoxi c injury, with L-carnit ine and palmitic acid being bene®cial and glucose deleterious to tissue repair (Chanda e t a l. 1996 ) . Tak en together, these results suggest that the protection of NAR livers from the cirrhotic process of prolonged exposure to TA is mainly due to the high source of fatty acid in these rat s necessary for optimal periportal hepatocyte regeneration.
Interestingly, ®brosis occurred in TAtreated NAR and was largely developed in NAR receiving a 10-m onth TA administration in drinking water. T his observation highlights the fact that fatt y acids or cholesterol overload of NAR cannot protect against the development of ®brosis. T his is further supported by the work of Nanji e t a l. (1997) demonstrating that dietary cholesterol supplementation in ethanol-induced cirrhosis rats prevents necrosis and in¯ammati on of the liver but increases the deposition of collagen and therefore of ®brosis, and by the work of Buko e t a l. (1997) reporting that a co-administration of anti-oxidative prostaglandins, inhibitors of lipid peroxidati on, to TA-treat ed rats resulted in a reduction of the extent of liver cirrhosis but did not affect the ®brotic state of the liver. T hese results strongly suggest that ®brosis and cirrhosis are two distinct processes. Further work is required to assess whether ®brosis is a part of regeneration or continuum of injury.
T he ductular cholangiocellular proliferation that we observed in NAR receiving prolonged TA administration has also been observed in rat s (Muller e t a l. 1996, Al-Bader e t a l. 2000) and re¯ects carcinoma development which is associated with TA treatm ent (Zimmermann e t a l. 1986, Hruban e t a l. 1966). Our observation further suggests that the cellular mechanisms involved in TA-induced cholangiolar proliferat ion and cirrhosis are two distinct processes.
In conclusion, the present study shows that prolonged TA administration to NAR does not induce cirrhosis development but induces ®brosis and cholangiolar proliferation, demonstrating separate mechanisms of TA-m ediated toxicity at the cellular level. T he fact that cirrhosis could be prevented in the inherently hyperlipidaemic and hypercholesterolaemic NAR could be considered for potential applicati on in the treatm ent of clinical cirrhosis.
